Stockscreener 앱 받기
2.63
1.54%
0.04
시간 외 거래:
2.63
전일 마감가:
$2.59
열려 있는:
$2.61
하루 거래량:
269.97K
Relative Volume:
0.06
시가총액:
$45.59M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.38%
1개월 성능:
+134.82%
6개월 성능:
-25.28%
1년 성능:
-30.79%
1일 변동 폭
$2.56
$2.66
1주일 범위
$2.4775
$2.66
52주 변동 폭
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.63 | 45.59M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Form 8.3Mural Oncology plc - Business Wire
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com India
Goldman Sachs adjusts position in Mural Oncology - Investing.com
Layoff Tracker: Pliant Cuts 45% of Staff To Extend Cash Runway - BioSpace
Geode Capital Management LLC Sells 9,027 Shares of Mural Oncology plc (NASDAQ:MURA) - Defense World
Goldman Sachs adjusts positions in Mural Oncology shares By Investing.com - Investing.com Nigeria
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com Canada
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Goldman Sachs adjusts positions in Mural Oncology shares - Investing.com
Goldman Sachs discloses stake in Mural Oncology - Investing.com Australia
Renaissance Technologies LLC Boosts Stock Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World
Ovarian Cancer Market: Epidemiology, Therapies, Companies, - openPR.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology plc - Investing.com
Goldman Sachs adjusts stake in Mural Oncology - Investing.com
Goldman Sachs adjusts stake in Mural Oncology By Investing.com - Investing.com South Africa
Mural Oncology plc Opening Position Disclosure Under Irish Takeover Rules - Nasdaq
FORM 8.1(a) & (b)Mural Oncology plc - The Manila Times
Mural Oncology Takeover Speculation Heats Up as CEO Stakes Revealed: 900K+ Total Shares - Stock Titan
Tang Capital reports stake in Mural Oncology - Investing.com
March sees multiple phase III successes, boosting Corcept and Mineralys - BioWorld MedTech
LMR Partners reports 2.997% stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology amid takeover rules By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology - Investing.com Australia
BlackRock discloses stake in Mural Oncology amid takeover rules - Investing.com Australia
LMR Partners reports 2.997% stake in Mural Oncology - Investing.com Australia
Tang Capital discloses stake in Mural Oncology By Investing.com - Investing.com India
Tang Capital discloses stake in Mural Oncology - Investing.com
Solas Capital discloses dealings in Mural Oncology shares By Investing.com - Investing.com India
Solas Capital discloses dealings in Mural Oncology shares - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com India
BlackRock reports stake in Mural Oncology - Investing.com Australia
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.84%
0.15%
자본화:
|
볼륨(24시간):